In the article titled "The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China" \[[@B1]\], there was an error in the value of the deceased patients, in the legend of [Table 5](#tab1){ref-type="table"}, where "(*n* = XXX)" should be corrected to "(*n* = 9)." The corrected table and its legend are shown below.

###### 

Information of the deceased patients with SJS/TEN in this study (*n* = 9).

  Phenotype   Sex   Age, y   Underlying disease                                                                                 SCORTEN   Culprit drugs                                                                    Treatment
  ----------- ----- -------- -------------------------------------------------------------------------------------------------- --------- -------------------------------------------------------------------------------- ----------------------------------------------------
  SJS         M     51       Chronic renal failure, diabetes                                                                    4         Allopurinol                                                                      Systemic steroids
  TEN         M     70       Nil                                                                                                6         Antibiotics                                                                      Systemic steroids
  TEN         F     58       Aneurysm, subarachnoid hemorrhage                                                                  NA        Antibiotics                                                                      Systemic steroids
  TEN         F     67       Rheumatic heart disease, mitral insufficiency                                                      NA        Antibiotics and compound with aminopyrine, phenacetin, caffeine, phenobarbital   Systemic steroids with IVIG use in the late stage
  TEN         F     71       Coronary heart disease, hypertension, diabetes, diabetic nephropathy                               4         Calcium dobesilate                                                               Systemic steroids with IVIG use in the early stage
  TEN         M     62       Hypertension, diabetes                                                                             NA        Antibiotics                                                                      Systemic steroids with IVIG use in the early stage
  TEN         M     94       Coronary heart disease, cardiac insufficiency, hypertension, diabetes, interstitial lung disease   NA        Antibiotics                                                                      Systemic steroids with IVIG use in the early stage
  TEN         M     62       Hypertension, diabetes, chronic renal failure, hyperuricemia                                       NA        Allopurinol                                                                      Systemic steroids
  TEN         M     3        Nil                                                                                                2         Antibiotics                                                                      Systemic steroids

IVIG use in the early stage ≤ 7 days of onset, IVIG use in the late stage ≥ 7 days of onset. NA: not available.
